JCO PRECIS ONCOL 润色咨询

JCO Precision Oncology

出版年份：暂无数据 年文章数：928 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2254902, encodeId=bf31225490200, content=投稿命中率:25.0<br>经验分享：投了快半个月了，一点动静都莫得，还在with editor...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000674620362, createdTime=Thu Mar 06 17:13:36 CST 2025, time=2025-03-06, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2216013, encodeId=e23b2216013c1, content=投稿快一个月了，还在with editor阶段，可不可以快点给决定嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Sun Jul 21 08:56:11 CST 2024, time=2024-07-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206128, encodeId=28742206128ca, content=中科院二区，有无希望更进一步。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/c9fdbe66f95773ba668f97f3acc55144.jpg, createdBy=a1b21607112, createdName=flytom, createdTime=Thu May 23 07:50:45 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204096, encodeId=05bb1204096f5, content=新刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 19 16:08:57 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116705, encodeId=93a91116e05e2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116706, encodeId=21261116e065b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2025-03-06 ms6000000674620362 来自福建省

    投稿命中率:25.0
    经验分享：投了快半个月了，一点动静都莫得，还在with editor....

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2254902, encodeId=bf31225490200, content=投稿命中率:25.0<br>经验分享：投了快半个月了，一点动静都莫得，还在with editor...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000674620362, createdTime=Thu Mar 06 17:13:36 CST 2025, time=2025-03-06, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2216013, encodeId=e23b2216013c1, content=投稿快一个月了，还在with editor阶段，可不可以快点给决定嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Sun Jul 21 08:56:11 CST 2024, time=2024-07-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206128, encodeId=28742206128ca, content=中科院二区，有无希望更进一步。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/c9fdbe66f95773ba668f97f3acc55144.jpg, createdBy=a1b21607112, createdName=flytom, createdTime=Thu May 23 07:50:45 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204096, encodeId=05bb1204096f5, content=新刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 19 16:08:57 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116705, encodeId=93a91116e05e2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116706, encodeId=21261116e065b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-07-21 ms4000000067455992 来自湖北省

    投稿快一个月了，还在with editor阶段，可不可以快点给决定嘞

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2254902, encodeId=bf31225490200, content=投稿命中率:25.0<br>经验分享：投了快半个月了，一点动静都莫得，还在with editor...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000674620362, createdTime=Thu Mar 06 17:13:36 CST 2025, time=2025-03-06, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2216013, encodeId=e23b2216013c1, content=投稿快一个月了，还在with editor阶段，可不可以快点给决定嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Sun Jul 21 08:56:11 CST 2024, time=2024-07-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206128, encodeId=28742206128ca, content=中科院二区，有无希望更进一步。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/c9fdbe66f95773ba668f97f3acc55144.jpg, createdBy=a1b21607112, createdName=flytom, createdTime=Thu May 23 07:50:45 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204096, encodeId=05bb1204096f5, content=新刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 19 16:08:57 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116705, encodeId=93a91116e05e2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116706, encodeId=21261116e065b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-05-23 flytom 来自广东省

    中科院二区，有无希望更进一步。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2254902, encodeId=bf31225490200, content=投稿命中率:25.0<br>经验分享：投了快半个月了，一点动静都莫得，还在with editor...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000674620362, createdTime=Thu Mar 06 17:13:36 CST 2025, time=2025-03-06, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2216013, encodeId=e23b2216013c1, content=投稿快一个月了，还在with editor阶段，可不可以快点给决定嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Sun Jul 21 08:56:11 CST 2024, time=2024-07-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206128, encodeId=28742206128ca, content=中科院二区，有无希望更进一步。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/c9fdbe66f95773ba668f97f3acc55144.jpg, createdBy=a1b21607112, createdName=flytom, createdTime=Thu May 23 07:50:45 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204096, encodeId=05bb1204096f5, content=新刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 19 16:08:57 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116705, encodeId=93a91116e05e2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116706, encodeId=21261116e065b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-03-19 医者仁者

    新刊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2254902, encodeId=bf31225490200, content=投稿命中率:25.0<br>经验分享：投了快半个月了，一点动静都莫得，还在with editor...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000674620362, createdTime=Thu Mar 06 17:13:36 CST 2025, time=2025-03-06, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2216013, encodeId=e23b2216013c1, content=投稿快一个月了，还在with editor阶段，可不可以快点给决定嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Sun Jul 21 08:56:11 CST 2024, time=2024-07-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206128, encodeId=28742206128ca, content=中科院二区，有无希望更进一步。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/c9fdbe66f95773ba668f97f3acc55144.jpg, createdBy=a1b21607112, createdName=flytom, createdTime=Thu May 23 07:50:45 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204096, encodeId=05bb1204096f5, content=新刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 19 16:08:57 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116705, encodeId=93a91116e05e2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116706, encodeId=21261116e065b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 Mia

    引言和讨论如何写的不重复？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2254902, encodeId=bf31225490200, content=投稿命中率:25.0<br>经验分享：投了快半个月了，一点动静都莫得，还在with editor...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000674620362, createdTime=Thu Mar 06 17:13:36 CST 2025, time=2025-03-06, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2216013, encodeId=e23b2216013c1, content=投稿快一个月了，还在with editor阶段，可不可以快点给决定嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Sun Jul 21 08:56:11 CST 2024, time=2024-07-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206128, encodeId=28742206128ca, content=中科院二区，有无希望更进一步。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/28/c9fdbe66f95773ba668f97f3acc55144.jpg, createdBy=a1b21607112, createdName=flytom, createdTime=Thu May 23 07:50:45 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204096, encodeId=05bb1204096f5, content=新刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 19 16:08:57 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116705, encodeId=93a91116e05e2, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116706, encodeId=21261116e065b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 小动量

    和讨论比，引言撰写的方式有什么不同？

    1

    展开1条回复
共11条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分